Qeios

Qeios is a United Kingdom-based academic publishing platform and multidisciplinary Open Science journal, headquartered in London. It positions itself as more than a traditional journal, describing itself as a platform designed to meet modern academic needs by combining human expertise with advanced AI. Its stated mission is to make academic publishing accessible, transparent, and efficient, fostering a research community that values open communication, rapid dissemination of knowledge, and constructive feedback. The platform operates an ISSN (2632-3834) and covers research across multiple broad domains, including Health Sciences, Life Sciences, Physical Sciences, and Social Sciences. Content types visible on the platform include commentaries, review articles, and other scholarly contributions. Qeios states that its work is indexed in Europe PMC, Google Scholar, the NIH COVID-19 portfolio, and other services. Qeios's distinctive feature is its reimagined peer review process. Authors submit a paper, which undergoes AI-assisted pre-checks for non-scientific content and plagiarism, and is posted as a preprint within one business day. The platform then uses custom-built AI to identify and invite appropriate peer reviewers, while spontaneous reviewers may also join. All identities and reviews are AI-checked for suitability. The process is fully transparent: reviewers sign their feedback, which is posted alongside the article, and they disclose potential conflicts of interest. Reviews include numerical scores that determine approval and give readers a deeper understanding of a paper's value. Authors can submit revised versions based on peer feedback. Once a paper secures at least four peer reviews with average ratings of 3 out of 5 or higher for overall, clarity, and impact, and 2.5 or higher for novelty, authors may opt to publish it as a regular article. According to the platform, more than 100,000 researchers already use Qeios, with contributors from over 150 countries and more than 200,000 readers exploring new research every month. The platform is used by researchers at various institutions, and it has been endorsed by academics such as Robert West, Professor of Health Psychology at University College London, who praised its formula of using AI to find and invite reviewers and publishing reviews alongside articles, enabling rapid review and improvement of works. Qeios operates as a private company in London, United Kingdom. It offers free sign-up for researchers and provides options to request more information. Its model reflects broader trends in open science, rapid dissemination, and transparent peer review in scholarly communication.

Qeios is a London-based company operating a multidisciplinary Open Science publishing platform. It emerged as part of a broader movement toward open science and transparent peer review in scholarly communication, aiming to address perceived inefficiencies in traditional academic publishing. The platform was designed to combine human expertise with advanced AI. Its core innovation is a reimagined peer review process: authors submit papers that undergo AI-assisted pre-checks for non-scientific content and plagiarism, and are posted as preprints within one business day. Custom-built AI identifies and invites appropriate peer reviewers, while spontaneous reviewers can also join. All identities and reviews are AI-checked for suitability. Reviews are fully transparent—reviewers sign their feedback, which is published alongside the article, and disclose potential conflicts of interest. Reviews include numerical scores that determine approval and inform readers about a paper's value. Authors can submit revised versions based on feedback. Once a paper secures at least four peer reviews with average ratings of 3 out of 5 or higher for overall, clarity, and impact, and 2.5 or higher for novelty, authors may opt to publish it as a regular article. Qeios operates under ISSN 2632-3834 and covers Health Sciences, Life Sciences, Physical Sciences, and Social Sciences. It states that its content is indexed in Europe PMC, Google Scholar, the NIH COVID-19 portfolio, and other services. The platform reports over 100,000 researchers using it, contributors from more than 150 countries, and over 200,000 monthly readers. It has been endorsed by academics such as Robert West, Professor of Health Psychology at University College London, who highlighted the speed and transparency of its review process. As a private company headquartered in London, United Kingdom, Qeios continues to develop its platform and promote its model of rapid, transparent, AI-assisted publishing.

A multidisciplinary Open Science platform combining human expertise with advanced AI to deliver accessible, transparent, and efficient academic publishing with rapid, signed peer review.

• Qeios Open Science publishing platform

  A multidisciplinary platform for preprint posting, AI-assisted peer review, and journal publication across Health Sciences, Life Sciences, Physical Sciences, and Social Sciences.

1. 1Qeios - Research you can trustqeios.com
2. 2About Qeiosqeios.com
3. 3Qeios (United Kingdom) - Wikidatawikidata.org